Thomas Engstrom
Clinical trials sponsored by Thomas Engstrom, explained in plain language.
-
Ambulance steroid shot may cut heart attack deaths in major trial
Disease control Recruiting nowThis study tests whether a single high-dose steroid (methylprednisolone) given in the ambulance before emergency heart artery opening can reduce deaths in people having a severe heart attack (STEMI). About 5,200 adults with chest pain and signs of a major heart attack will be ran…
Phase: PHASE3 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated May 26, 2026 05:29 UTC
-
New heart attack procedures aim to save lives and prevent heart failure
Disease control Recruiting nowThis study is testing two methods used during emergency heart attack treatment to see if they improve patient outcomes. The first method, called ischemic postconditioning, involves briefly interrupting blood flow after opening the blocked artery. The second uses ultrasound guidan…
Phase: NA • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Can late heart attack treatment still save heart muscle?
Knowledge-focused Recruiting nowThis study looks at whether opening a blocked artery more than 12 hours after a heart attack helps patients. It involves 150 adults who are stable and had a heart attack 12 to 36 hours earlier. Researchers will use MRI scans to measure how much heart muscle is saved and how well …
Phase: NA • Sponsor: Thomas Engstrom • Aim: Knowledge-focused
Last updated May 26, 2026 05:43 UTC